Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

BNC210

Product Specifications

UNSPSC Description

BNC210 (H-Ile-Trp-OH) is an orally active α7 nAChR negative alteration modulator (NAM) with no apparent side effects. BNC210 exhibits acute anxiolytic activity in rodent models of anxiety. BNC210 inhibits rat and human α7 nAChR currents (in stably transfected cell lines) induced by acetylcholine, nicotine, choline, and the a7-specific agonist PNU-282987 with IC50 values in the range of 1.2 to 3 μM. BNC210 can be used in studies of anxiety, trauma, and stressor-related disorders[1][2][3][4].

Target Antigen

nAChR

Type

Reference compound

Related Pathways

Membrane Transporter/Ion Channel;Neuronal Signaling

Applications

Neuroscience-Neuromodulation

Field of Research

Neurological Disease

Assay Protocol

https://www.medchemexpress.com/bnc210.html

Purity

98.03

Solubility

DMSO : 125 mg/mL (ultrasonic)

Smiles

O=C([C@@H](N)[C@@H](C)CC)N[C@H](C(O)=O)CC1=CNC2=C1C=CC=C2

Molecular Weight

317.38

References & Citations

[1]Wise T, et al. Cholinergic modulation of disorder-relevant neural circuits in generalized anxiety disorder. Biological psychiatry, 2020, 87(10): 908-915. |[2]Hampsey E, et al. BNC210: an investigational α7-nicotinic acetylcholine receptor modulator for the treatment of anxiety disorders. Expert Opin Investig Drugs. 2023 Apr;32(4):277-282.|[3]O'Connor SM, et al. BNC210, a negative allosteric modulator of the alpha 7 nicotinic acetylcholine receptor, demonstrates anxiolytic- and antidepressant-like effects in rodents. Neuropharmacology. 2024 Mar 15;246:109836.|[4]Andriambeloson E, et al. BNC210: A Novel Compound with Potent Anxiolytic Activity[C]//BEHAVIOURAL PHARMACOLOGY. 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA: LIPPINCOTT WILLIAMS & WILKINS, 2007, 18: S16-S16.

Shipping Conditions

Room Temperature

Storage Conditions

-20°C, 3 years; 4°C, 2 years (Powder)

Product Datasheet

http://file.medchemexpress.com/batch_PDF/HY-105858/BNC210-DataSheet-MedChemExpress.pdf

Product MSDS

http://file.medchemexpress.com/batch_PDF/HY-105858/BNC210-SDS-MedChemExpress.pdf

Clinical Information

Phase 3

CAS Number

13589-06-5

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

PSME2 Antibody, Biotin conjugated
CSB-PA01134D0Rb-01 50 µg

PSME2 Antibody, Biotin conjugated

Ask
View Details
PSME2 Antibody, Biotin conjugated
CSB-PA01134D0Rb-02 100 µg

PSME2 Antibody, Biotin conjugated

Ask
View Details
GADD34 Polyclonal Antibody Bio Conjugated
C90471Bio 100 µL

GADD34 Polyclonal Antibody Bio Conjugated

Ask
View Details
c-erbB2 (HER-2, neu Receptor) (BSA & Azide Free) (MaxLight 405)
MBS6267169-01 0.1 mL

c-erbB2 (HER-2, neu Receptor) (BSA & Azide Free) (MaxLight 405)

Ask
View Details
c-erbB2 (HER-2, neu Receptor) (BSA & Azide Free) (MaxLight 405)
MBS6267169-02 5x 0.1 mL

c-erbB2 (HER-2, neu Receptor) (BSA & Azide Free) (MaxLight 405)

Ask
View Details
TAS2R43 Human qPCR Primer Pair (NM_176884)
HP218712 200 Reactions

TAS2R43 Human qPCR Primer Pair (NM_176884)

Ask
View Details